Analyst Ratings for Anthera Pharma (ANTH) [Neutrals]

ANTH Rating Summary

ANTH Price Target Summary

  |   Expand Research on ANTH
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $7.86 (+1188.1%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
6/28/2012 JMP Securities Downgrade Market Perform
(Market Outperform)
N/A
(N/A)
2.75 0.61 -77.82% Details
3/12/2012 Cowen Downgrade Neutral
(N/A)
N/A
(N/A)
3.16 0.61 -80.7% Details
Like ANTH Ratings? Also take a look at GSK, HGSI

ANTH Ratings News